Lactobacillus rhamnosus GG administration was also able to protect the NAFLD progression by reducing hepatic expression of IL-1β, IL-8R, and TNF-α; increasing LPS accumulation; and increasing beneficial bacteria in the NAFLD model provoked through a high-fructose regime [140]. This evidence concerns the gene IL1B and metabolic dysfunction-associated steatotic liver disease.